Skip to content

Concurrent Treatment for Depressed Parents and DepressedAdolescents

Concurrent Treatment for Parents and Adolescents Who Attempt Suicide

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00951821
Enrollment
24
Registered
2009-08-04
Start date
2009-07-31
Completion date
2013-12-31
Last updated
2015-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression, Suicide

Keywords

Suicidal Ideation, Suicide Attempts

Brief summary

This study will develop an integrated treatment for adolescents who are depressed and suicidal and their parents who are depressed and have a history of suicidality.

Detailed description

Depression, like many psychiatric disorders, has a genetic component that makes it more likely that members of the same family will have the disorder. Depression in parents, particularly mothers, may put the children at greater risk for depression. When an adolescent whose parent is depressed develops depression himself or herself, treating both the parent and the adolescent may be more effective than treating only the adolescent. This study will test a depression treatment that targets depressed suicidal adolescents with a parent or primary caretaker who is also depressed and has a history of suicidality. Participation in this study will last 6 months. Participants will be randomly assigned to receive either concurrent parent and adolescent treatment or adolescent only treatment. For those assigned to concurrent treatment, both the adolescent participants and one of their parents will receive individual cognitive behavioral therapy (CBT) counseling sessions and joint family counseling sessions. In the adolescent only treatment condition, adolescent participants will receive individual CBT sessions, but parents will not, and both will receive joint family sessions. Counseling sessions will last 1 hour and occur weekly for 3 months, and then every other week for 3 months. CBT identifies and attempts to change problematic thought patterns. All participants will receive medication consultation if necessary. Participants will complete assessments at baseline, post-treatment, and 6 months after completing treatment. These assessments will include questionnaires and interviews about depression, suicidal thoughts, mood regulation, behavioral problems, and family. At post-treatment and the 6-month follow-up, participants will also be asked to give feedback about the counseling, medication consultation, and their satisfaction.

Interventions

BEHAVIORALConcurrent treatment

Individual CBT sessions for parents and adolescents plus combined parent-adolescent family sessions, delivered weekly for 3 months in the acute phase and bimonthly for 3 months in the maintenance phase. The techniques used to teach cognitive restructuring and problem solving to parents will be similar to those taught to the adolescents, except emotion regulation skills will be added to the parent treatment.

BEHAVIORALAdolescent treatment only

Individual CBT for adolescents only plus combined parent-adolescent family sessions, delivered weekly for 3 months in the acute phase and bimonthly for 3 months in the maintenance phase

Sponsors

National Institute of Mental Health (NIMH)
CollaboratorNIH
Brown University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
12 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

for Adolescents: * Lives at home with at least one parent or guardian * Speaks English * Must have made a suicide attempt and be diagnosed with major depressive disorder (MDD) Inclusion Criteria for Primary Caretakers: * Speaks English * Current diagnosis of MDD and a history of suicidality

Exclusion criteria

for Adolescents: * Judged to have developmental or cognitive delays or psychotic disorders on the basis of a standard psychiatric exam * Diagnosis of bipolar disorder or a substance dependence (people with a diagnosis of substance abuse are eligible) * Only one adolescent per family is eligible

Design outcomes

Primary

MeasureTime frameDescription
Beck Depression Inventory - Adolescent Report, Change in Symptom Level12 monthsself-report measure of depressed mood - range of scores 0 to 60; higher scores indicate worse depression. The data in this outcome refer to change from baseline to 12 month follow-up, per the adolescent self-report.

Secondary

MeasureTime frameDescription
Beck Suicide Scale - Adolescent ResponseMeasured at 12 monthsmeasure of suicidal ideation - scale ranges from 0 to 38 - higher scores indicate higher suicidal ideation. These data refer to adolescent respondents. The outcome is a change score so range is from -38 to 38.

Countries

United States

Participant flow

Participants by arm

ArmCount
Concurrent Treatment
Adolescent participants and their parents will receive concurrent cognitive behavioral therapy. Concurrent cognitive behavioral therapy (CBT): Individual CBT sessions for parents and adolescents plus combined parent-adolescent family sessions, delivered weekly for 3 months in the acute phase and bimonthly for 3 months in the maintenance phase. The techniques used to teach cognitive restructuring and problem solving to parents will be similar to those taught to the adolescents, except emotion regulation skills will be added to the parent treatment.
16
Adolescent Treatment Only
Only adolescent participants will receive cognitive behavioral therapy. Adolescent only cognitive behavioral therapy (CBT): Individual CBT for adolescents only plus combined parent-adolescent family sessions, delivered weekly for 3 months in the acute phase and bimonthly for 3 months in the maintenance phase
8
Total24

Baseline characteristics

CharacteristicConcurrent TreatmentTotalAdolescent Treatment Only
Age, Continuous14.69 years
STANDARD_DEVIATION 1.78
14.45 years
STANDARD_DEVIATION 1.72
14.0 years
STANDARD_DEVIATION 1.69
Beck Depression Inventory29.32 units on a scale24.65 units on a scale19.13 units on a scale
Beck Suicide Ideation Scale9.81 units on a scale8.12 units on a scale5.75 units on a scale
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants2 Participants1 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
15 Participants22 Participants7 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
1 Participants1 Participants0 Participants
Race (NIH/OMB)
More than one race
2 Participants3 Participants1 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
3 Participants5 Participants2 Participants
Race (NIH/OMB)
White
10 Participants15 Participants5 Participants
Region of Enrollment
United States
16 participants24 participants8 participants
Sex: Female, Male
Female
14 Participants20 Participants6 Participants
Sex: Female, Male
Male
2 Participants4 Participants2 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
2 / 161 / 8
serious
Total, serious adverse events
5 / 162 / 8

Outcome results

Primary

Beck Depression Inventory - Adolescent Report, Change in Symptom Level

self-report measure of depressed mood - range of scores 0 to 60; higher scores indicate worse depression. The data in this outcome refer to change from baseline to 12 month follow-up, per the adolescent self-report.

Time frame: 12 months

Population: intent to treat

ArmMeasureValue (MEAN)Dispersion
Concurrent TreatmentBeck Depression Inventory - Adolescent Report, Change in Symptom Level-17.5 change in BDI (-60 to 60 possible range)Standard Error 2.8
Adolescent Treatment OnlyBeck Depression Inventory - Adolescent Report, Change in Symptom Level-14.1 change in BDI (-60 to 60 possible range)Standard Error 3.4
p-value: 0.4695% CI: [-12.1, 5.5]Mixed Models Analysis
Secondary

Beck Suicide Scale - Adolescent Response

measure of suicidal ideation - scale ranges from 0 to 38 - higher scores indicate higher suicidal ideation. These data refer to adolescent respondents. The outcome is a change score so range is from -38 to 38.

Time frame: Measured at 12 months

Population: intent to treat

ArmMeasureValue (MEAN)Dispersion
Concurrent TreatmentBeck Suicide Scale - Adolescent Response-1.7 units on a scaleStandard Error 1.4
Adolescent Treatment OnlyBeck Suicide Scale - Adolescent Response-2.1 units on a scaleStandard Error 1.3
p-value: 0.7595% CI: [-2.36, 3.06]Mixed Models Analysis

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026